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A large-scale genomic investigation of
susceptibility to infection and its association with
mental disorders in the Danish population
Ron Nudel 1,2, Yunpeng Wang 2,3, Vivek Appadurai1,2, Andrew J. Schork1,2, Alfonso Buil 1,2, Esben Agerbo 2,4,5,
Jonas Bybjerg-Grauholm 2,6, Anders D. Børglum 2,7,8, Mark J. Daly 9, Ole Mors2,10, David M. Hougaard 2,6,
Preben B. Mortensen2,4, Thomas Werge1,2,11, Merete Nordentoft2,11,12, Wesley K. Thompson1,2,13 and
Michael E. Benros 2,12
Abstract
Infections and mental disorders are two of the major global disease burdens. While correlations between mental
disorders and infections have been reported, the possible genetic links between them have not been assessed in
large-scale studies. Moreover, the genetic basis of susceptibility to infection is largely unknown, as large-scale genome-
wide association studies of susceptibility to infection have been lacking. We utilized a large Danish population-based
sample (N= 65,534) linked to nationwide population-based registers to investigate the genetic architecture of
susceptibility to infection (heritability estimation, polygenic risk analysis, and a genome-wide association study
(GWAS)) and examined its association with mental disorders (comorbidity analysis and genetic correlation). We found
strong links between having at least one psychiatric diagnosis and the occurrence of infection (P= 2.16 × 10−208, OR
= 1.72). The SNP heritability of susceptibility to infection ranged from ~2 to ~7% in samples of differing psychiatric
diagnosis statuses (suggesting the environment as a major contributor to susceptibility), and polygenic risk scores
moderately but significantly explained infection status in an independent sample. We observed a genetic correlation
of 0.496 (P= 2.17 × 10−17) between a diagnosis of infection and a psychiatric diagnosis. While our GWAS did not
identify genome-wide significant associations, we found 90 suggestive (P ≤ 10−5) associations for susceptibility to
infection. Our findings suggest a genetic component in susceptibility to infection and indicate that the occurrence of
infections in individuals with mental illness may be in part genetically driven.
Introduction
Infections are one of the major disease burdens and the
second leading cause of death worldwide1. Infections and
inflammation have also been linked to the development of
other diseases: autoimmune diseases, cancer, and neu-
ropsychiatric disorders such as schizophrenia and
depression2–6. Inter-individual differences influence the
susceptibility to infection, which is likely to depend on
environmental and social factors, vulnerable periods, such
as psychological stress or immunocompromised condi-
tions, and the host’s genetic profile7,8. Twin and adoption
studies as well as epidemiological studies have indicated
that hosts’ genetic makeups influence infectious disease
occurrences and outcomes of interactions between
infectious pathogens and hosts7–10. However, the genetic
architecture of susceptibility to infection is largely
unknown, and knowledge of the genetic composition of
infections may help elucidate the mechanism of human
complex diseases8,11.
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Genome-wide association studies (GWAS) have
improved our understanding of the genetic basis of
common diseases and been used to discover and replicate
associations between thousands of genomic variants and
hundreds of human diseases12. Only a few large-scale
studies of the genetics of susceptibility to infection have
been conducted, with the largest study being on self-
reported common infections and infection-associated
procedures11. A recent meta-analysis of pooled respira-
tory infection GWAS (including studies on tuberculosis,
influenza, respiratory syncytial virus, SARS-Coronavirus
and pneumonia) found only one significant single-
nucleotide polymorphism (SNP), in the IL4 gene7. Pre-
vious studies have often provided conflicting results and
been hampered by low power, differences in study
designs, and/or high risk of publication bias7. Recently,
acknowledging the potential links between psychiatric
disorders and infection, studies looking into the genetic of
specific infections have been performed, including a study
of infection (Toxoplasma gondii, Herpes simplex virus 1,
Cytomegalovirus and Human herpesvirus 6) and inflam-
mation in individuals with schizophrenia and bipolar
disorder13, and a study of Toxoplasma gondii in indivi-
duals with schizophrenia14 highlighted several genes and/
or pathways.
In this largest genetic study of infections requiring
hospital contact (hereafter: infections), we utilize a
population-based Danish cohort of 65,534 genotyped
individuals to conduct a genetic study of overall infection
(i.e. a phenotype comprising multiple infection categories,
see Methods) from birth to the end of follow-up. The
cohort was sampled through the Integrative Psychiatric
Research (iPSYCH) initiative15, with individuals selected
for having a at least one of: autism spectrum disorder
(ASD), attention deficit hyperactivity disorder (ADHD),
schizophrenia, depression, bipolar disorder and anorexia,
as well as a random population sample. We investigate the
genetic architecture of susceptibility to infection and
examine the link between infections and mental disorders.
Methods
Data sources
Data were obtained by linking Danish population-based
registers using the unique personal identification number
employed in Denmark since 196816. The Danish Neonatal
Screening Biobank stores dried blood spots taken
4−7 days after birth from nearly all infants born in
Denmark after 198116,17. Information about infections
was obtained from the Danish National Hospital Registry,
which, since 1977, contains records of all inpatients
treated in Danish nonpsychiatric hospitals, and, since
1995, contains information regarding outpatient and
emergency room contacts18. The Psychiatric Central
Research Register covers all psychiatric inpatient facilities
since 1969 and outpatient contacts since 199519. Diag-
nostic information was based on the Eighth Revision of
the International Classification of Diseases (ICD-8)20 from
1977 to 1993, and ICD-10 from 199421.
Study sample
All singletons born in Denmark between May 1, 1981
and December 31, 2005 who were residents of Denmark
on their first birthday and have a known mother (N=
1,472,762) were considered. From this group, 86,189
individuals were included in the iPSYCH2012 sample.
Before quality control (QC) our sample included
78,050 successfully genotyped individuals. Following QC,
65,534 individuals remained: 19,645 individuals with no
hospital contacts for psychiatric diagnoses (none of ICD-
10: F00−F99), and 45,889 individuals with one or more of
the following mental disorders: ASD (F84.0-1, F84.5,
F84.8-9; N= 12,331), ADHD (F90.0; N= 14,397), schi-
zophrenia (F20; N= 2401), bipolar disorder (F30−F31; N
= 1391), single and recurrent depressive disorder (F32
−F33; N= 18,511) and anorexia nervosa (F50.0; N=
2551). These diagnoses are based on data from the Danish
Psychiatric Central Research Register only. A minority of
these individuals (N= 1993) have been diagnosed with
other psychiatric disorders (other codes in F00−F99) and
originally included as part of the random population
sample. Individual-based data were available until emi-
gration, death, or 31 December 2012 of a given individual.
Three subsets were used across the analyses in this study:
only the individuals without psychiatric diagnosis (no F00
−F99 diagnosis), only the individuals with psychiatric
diagnosis (primary or secondary iPSYCH diagnosis of F00
−F99), or a combined sample with a covariate for having a
psychiatric diagnosis. More details are given in the rele-
vant sections. With regards to the infection diagnoses,
Supplementary Table S1 includes sample sizes for all
infection categories. All hospital contacts for infections
(both in- and outpatient hospital contacts) were included
with ICD-8 and ICD-10 codes listed in Supplementary
Table S2, as used in previous studies4,22,23, and each
person may have a history of more than one infection. We
omitted all diagnoses listed as “suspected” or “not found”.
Controls for infections were defined as having none of the
infection diagnoses in Table S1, and controls for psy-
chiatric disorders were defined as not having any ICD-10
diagnosis of F00−F99 in the Danish Psychiatric Central
Research Register, unless stated otherwise.
Genetic markers, quality control for markers and samples,
and imputation
Samples were genotyped on the Illumina Psych chip.
Before QC, there were 78,050 samples genotyped in 23 of
the original 25 waves. A full description of the procedure
of the sample and SNP QC is provided elsewhere24.
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Briefly, a principal component analysis (PCA) was per-
formed using the iPSYCH sample with 1000 Genomes
Project samples as a reference panel to compute the initial
principal component space. Individuals whose parents
and grandparents were born in Denmark were used as a
reference in removing individuals who were a certain
distance from the multivariate mean of the joint dis-
tribution of the first ten PCs. This was then repeated using
only the iPSYCH sample to identify subtler within-
population differences. Samples were also removed
based on genotype missingness, abnormal heterozygosity
or ambiguous sex, based on genetic markers. Samples that
were identified as duplicates were also removed. Lastly,
samples that were found to be related to other samples
(first and second degree) were removed, whereby the
cases and then samples with a higher genotype call rate
were prioritized. Following this, a new PCA was per-
formed to obtain principal components for downstream
analyses. For the imputation, only autosomal SNPs were
used, and SNPs were removed based on low minor allele
frequency (<0.01), Hardy−Weinberg equilibrium P value
(<10−6), having more than two alleles, or being indels.
Genotypes were phased with SHAPEIT325 and imputed
with IMPUTE226. Imputed markers were removed if they
had an INFO score below 0.2, a MAF below 0.001, best-
guess genotypes missing in >10% of subjects, HWE P <
1 × 10−6 (in controls) or a highest probability for a gen-
otype of less than 0.9. Markers were also removed if they
were significantly associated with the genotyping wave.
Two marker datasets were used: in the GWAS, all post-
QC dosage data were used. This dataset included
11,600,722 markers. For the heritability, genetic correla-
tion and PRS analyses, which are based on an aggregation
of SNPs, the above dataset was filtered, resulting in a
dataset of high-confidence imputations (best-guess gen-
otypes), with markers having an INFO score of at least 0.8
and MAF of at least 0.01. This dataset included 7,071,055
markers. Positions throughout this paper are in hg19.
Exome-sequencing data
A subset of the iPSYCH sample was exome-sequenced
(with an average depth of 20×). Sequencing libraries were
produced using a custom adaptation of the Illumina Rapid
Target Kit (Illumina ICE Broad Exome) and sequenced on
Illumina Hiseqs. The raw reads were mapped using bwa
aln (v5.9)27 with the parameters -q 5 -l 32 -k 2 to GRCh37,
including unplaced and unlocalized contigs and Epstein
−Barr (NC_007605.1). PCR duplicates were removed
using picard MarkDuplicates, combined per sample, and
realigned across indels using GATK IndelRealigner28.
Variant-calling was performed using GATK’s Haplotype-
Caller. Variant filtration was performed using GATK’s
variant quality score recalibration modules and the variant
annotation was performed using SnpEff29. For the
analyses that used the exome-sequencing data only, given
that we looked only at mutations that may alter the
protein coding sequence, we utilized samples even if they
were excluded earlier based on relatedness and ancestry, if
they passed the other QC measures (N= 18,819).
Statistical analyses
Correlation between psychiatric diagnoses and infections
To examine differences in overall infection rates among
psychiatric cases and controls, chi-squared statistics were
calculated in R30. ORs and confidence intervals were
calculated using the DescTools package in R31. Following
this, we performed logistic regressions of the psychiatric
diagnosis on the infection diagnosis only in QC-passing
individuals from the random population sample, to avoid
potential bias resulting from the majority of the sample
having been selected for psychiatric disorders. This sec-
ond analysis used covariates for sex, age and age-squared
(to account for nonlinearity with age). The plot for this
analysis was exported from Excel with Daniel’s XL
Toolbox32.
SNP heritability
GCTA33 (v1.24.7 used with the control subset; v1.91.1
beta otherwise) was used to compute the SNP herit-
abilities for having any infectious disease. Genetic rela-
tionship matrices were calculated for each autosomal
chromosome separately with –make-grm and merged
with –mgrm. A GREML analysis was then performed with
covariates for age, age-squared, sex and the first ten PCs.
The analysis was done either with psychiatric controls,
psychiatric cases, or the entire sample with an added
covariate for having a psychiatric diagnosis.
Genetic correlation
A bivariate genetic correlation analysis between having
any infection and having any psychiatric diagnosis was
run with GCTA v1.91.1 beta, with –reml-bivar and cov-
ariates for age, age-squared, sex and the first ten PCs. A
Wald test was used to obtain a P value for the correlation
(assuming no correlation as the null). This was performed
in the large sample as well as only with individuals from
the random population sample. Additionally, LD score
regression v1.0.0 (from August 10 2018)34,35 was also used
to confirm the genetic correlation, since it is robust to
sample overlap35. For this purpose, two GWAS were
performed using the same SNP dataset as used with
GCTA: one GWAS for having any infection (without a
covariate for having any psychiatric diagnosis) and
another GWAS for having any psychiatric diagnosis (F00
−F99 in ICD-10). The above covariates were included in
both GWAS. LD scores were calculated with the same
SNP dataset using QC-passing samples from the random
population sample and a 1 cm window, and a genetic map
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from 1000 Genomes phase 3. The summary statistics
from the two GWAS were QCed with the LD score
regression package, after which the genetic correlation
was computed.
Genome-wide association study
Dosage data were used with PLINK36 v1.90b3.34 in a
logistic regression model with covariates for age, age-
squared, sex, any psychiatric diagnosis, and the first ten
PCs. The phenotype used in the GWAS was having any
infection.
Polygenic risk scores
PRSice37 v1.25 was used to calculate polygenic risk
scores (PRS). Given that we observe psychiatric patients
have a higher incidence of infections, the two variables are
not independent23. Also, the direction of causality is
unknown. To avoid creating PRS that could misrepresent
the genetic effects on infection risk (i.e., predicts psy-
chiatric outcomes, which, in turn, predict infection as an
environmental exposure) we develop our PRS for infec-
tions from a GWAS of infections in patients without
psychiatric outcomes (N= 19,645). We used the summary
statistics from this GWAS as the training dataset, and the
subset of psychiatric cases as the target sample (N=
45,889). As the PRS was trained in a nonpsychiatric
population, any PRS−infection correlations are not likely
to be mediated by the current expression of psychiatric
outcomes. Furthermore, any confounding between psy-
chiatric diagnoses and infection within the psychiatric
population should be independent of the infection PRS by
construction and should only contribute to residual var-
iation. In this context, our target sample (the psychiatric
cases) will have slightly less power to detect a reduced
effect of the PRS relative to a healthy population sample,
but the confound should not increase false positives. We
used an r2 threshold of 0.1 in a window of 250 kbp for
clumping. As both the training sample and target sample
used the same SNP dataset, there was a full overlap
between both samples in terms of marker data availability.
We ran PRSice with P value thresholds of 0.01−1 with
intervals of 0.01, and the regression included covariates
for age, age-squared, sex and the first ten PCs. From this,
we chose the optimal P value threshold for downstream
analysis.
Results
In the sample of 65,534 Danish unrelated individuals
born after 1981, a total of 28,472 individuals had infec-
tions during the study period from birth to end of follow-
up. Among the 45,889 individuals with mental disorders,
the number was 21,728, and, among the 19,645 indivi-
duals with no psychiatric diagnosis, it was 6744.
Epidemiological correlations
We observed a highly significant correlation between
having a psychiatric diagnosis and having an infection (P
= 2.16 × 10−208, OR= 1.72), including highly significant
individual correlations between the specific psychiatric
diagnoses and infection status (Table 1). To investigate
this link further and to account for age and sex, we per-
formed logistic regressions in the random population
sample; this avoids potential biases resulting from the
selection of cases for the iPSYCH cohort. As can be seen
in Fig. 1, the ORs and confidence intervals were greater
than 1 for all individual psychiatric disorders and for
having any psychiatric diagnosis. All P values were <0.05,
and all apart from the association with anorexia remained
significant after Bonferroni correction. With regards to
the individual psychiatric conditions, using controls who
do not have any other psychiatric diagnosis in addition to
the one in question may lead to biased estimates; we have
Table 1 Incidences of psychiatric diagnosis and infection status in our sample
Psychiatric diagnosis Total number of
individuals
Individuals with
infections
Individuals without
infections
P value Odds ratio (95%CI)
Any psychiatric diagnosis 45,889 21,728 24,161 2.16 × 10−208 1.72 (1.66−1.78)
ASD 12,331 5354 6977 7.96 × 10−60 1.47 (1.40−1.54)
ADHD 14,397 6730 7667 1.7 × 10−118 1.68 (1.61−1.75)
Schizophrenia 2401 1232 1169 4.53 × 10−60 2.02 (1.85−2.2)
Bipolar disorder 1391 699 692 3.48 × 10−33 1.93 (1.73−2.16)
Depression 18,511 9410 9101 2.83 × 10−233 1.98 (1.90−2.06)
Anorexia 2551 1094 1457 1.8 × 10−17 1.44 (1.32−1.56)
No psychiatric diagnosis
(reference)
19,645 6744 12,901 NA 1.00
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therefore examined if this is the case here, but the
observed effects obtained when defining controls as not
having only the diagnosis in question are very similar, as
shown in Fig. S1 (the OR for any psychiatric diagnosis is
included again as a reference).
Heritability analysis
We estimated the SNP heritability for overall sus-
ceptibility to infection to be 4% (P= 0.0018, SE= 0.015)
on the observed scale among individuals with no psy-
chiatric diagnosis, and it was 3.5% (P= 4.6 × 10−8, SE=
0.007) among individuals with a psychiatric diagnosis.
These estimates are not significantly different from each
other, as can be shown through a Z test38 (Z= 0.358,
two-sided P= 0.72). The heritability was estimated to be
3.2% (P= 1.3 × 10−12, SE= 0.005) in the combined
sample. To transform the observed heritabilities to
liability-scale heritabilities39, we adjusted for the pro-
portion of infection cases in the different groups as well
as for different values of the lifetime prevalence, k (the
iPSYCH individuals are too young to estimate the true
value of k), which allowed us to provide the maximal
bound for the heritabilities, given the proportions of
cases in our sample. The maximal values of the herit-
ability on the liability scale are around 7% in psychiatric
controls, 5.5% in psychiatric cases and 5% in the com-
bined sample (Fig. 2), suggesting a modest genetic
component for susceptibility to infection. Figure 2 also
shows the heritabilities for a k equal to the prevalence in
the QC-passing random population sample, which is the
minimal lifetime prevalence in our study.
Genetic correlation
The genetic correlation, rg, between having any infec-
tion diagnosis and having any psychiatric diagnosis was
0.496 (P= 2.17 × 10−17, SE= 0.058), where the separate
heritabilities (on the observed scale) as estimated in this
analysis were 3.8% (SE= 0.005) for infection, and 12.3%
(SE= 0.006) for psychiatric diagnosis. Since both pheno-
types were derived from the same sample, and to avoid
any potential ascertainment bias due to the high corre-
lation between them (and given that most individuals in
the sample were selected for having a psychiatric diag-
nosis), the genetic correlation analysis was repeated using
only QC-passing samples selected as part of the random
population sample (N= 21,706: 1062 individuals with
both phenotypes; 6693 individuals with only infections;
1113 individuals with only psychiatric diagnoses; 12,838
individuals with neither phenotype). While this analysis
had a reduced sample size due to the lower number of
psychiatric cases in particular, the observed correlation
was similar (rg= 0.518, SE= 0.208). Additionally, we
confirmed the genetic correlation using LD score regres-
sion, which is robust to sample overlap. The rg obtained
from this analysis was 0.407 (P= 9.1 × 10−5, SE= 0.104).
It is lower than the estimate obtained with GCTA (the
latter being potentially biased by the sample overlap), but
it is still quite large and significant.
PRS for infection and predictive value for acquiring
infections
The PRS for infection explained a small proportion of
the variance in the target sample. We used 100 P value
thresholds (pT) from the discovery GWAS (0.01−1).
After Bonferroni correction, all Nagelkerke R2’s resulting
from P value thresholds of 0.04 or higher remain sig-
nificant at an overall 5% level. The best-fit PRS was with
pT= 0.26, resulting in a Nagelkerke R2 of ~0.9% (P=
2.55 × 10−8). We additionally examined the change in the
proportion of infection cases across PRS deciles with the
best-fit PRS. We found that there was an overall trend of
Fig. 1 Logistic regressions of psychiatric disorders on infection status
Fig. 2 Transformation of the observed heritability of acquiring
infection as a function of the lifetime prevalence, k. Color coding
is blue for iPSYCH psychiatric controls, green for iPSYCH psychiatric
cases, and red for the combined sample (with a covariate for any
psychiatric diagnosis). Dashed lines show the heritability as estimated
using the prevalence in each group when k is estimated from the
random population sample
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an increased proportion of cases, with the difference
between the first and tenth deciles being ~5% (Fig. 3).
GWAS and exome-sequencing
No loci reached genome-wide significance (Fig. 4).
Supplementary Figure S2 is the accompanying QQ plot.
Overall, there were 90 suggestive associations with P ≤
10−5 (Supplementary Table S3), and the top SNP was
rs6447952 (P= 2.98 × 10−7, OR= 0.94 relative to the A
allele), which is an intronic SNP in the SLIT2 gene. Given
this gene’s role in both immunity and neurodevelopment
and recent findings from several studies concerning
disease-risk genes harboring both rare and common var-
iants influencing disease-related traits40, we screened a
subset of our sample which was exome-sequenced, for
potentially deleterious mutations in this gene. We con-
sidered frameshift indels, splice-site-, missense- and
nonsense-variants (hereafter referred to simply as muta-
tions). We identified 891 SLIT2 mutation carriers, of
whom 426 had at least one infection diagnosis (47.8%).
Fig. 3 Proportion of cases of infectious diseases at best-fit PRS
Fig. 4 Manhattan plot for the GWAS for overall infection in the combined sample. The red line on the Manhattan plot represents the genome-
wide significance threshold (5 × 10−8), and the blue line represents the suggestive association threshold (10−5). The plot was generated with the
“qqman” R script by Stephen Turner and Daniel Capurso
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17,928 individuals did not carry a mutation in SLIT2, and
8214 of those had at least one infection diagnosis (45.8%).
A hypergeometric test did not find a significant enrich-
ment of individuals with infections among mutation car-
riers (P= 0.117).
Discussion
In this population-based study we investigated the
genetic architecture of susceptibility to infection among
65,534 unrelated Danish individuals. Psychiatric diagnoses
were strongly linked with the occurrence of infections, an
effect which was observed also in regression models which
used a random sample of the Danish population. We
found that common genetic variation significantly
explained risk of susceptibility to overall infection, to
varying degrees, based on psychiatric diagnosis status. In a
recent study of the iPSYCH sample, most iPSYCH dis-
orders as well as a cross-disorder phenotype showed sig-
nificant heritabilities24. Given this and the observed
heritability for infection, we also examined the genetic
correlation between having an infection diagnosis and
having a psychiatric diagnosis. We found a strong genetic
correlation between the two. Additionally, the phenotype
captured by infection requiring hospitalizations showed a
polygenic pattern that significantly explained some of the
risk for overall infection in an independent sample, albeit
to a modest degree.
Differences in host genetics likely influence the host’s
susceptibility to infection. However, the combined results
of the heritability estimates, the PRS analysis, and the chi-
squared and regression analyses showing significant dif-
ferences in the rate of infection among psychiatric cases
and controls may suggest that the environmental com-
ponent may play a bigger role in acquiring infections. The
observed modest genetic contribution to infection indi-
cates that it is primarily nongenetic influences at work,
which is not surprising, as infections are most often
transient and are transmitted from one person to another.
Nonetheless, we found that the polygenic risk score for
infection could explain a small proportion of the variance
in terms of the risk of having an infection in an inde-
pendent sample, which is a novel finding.
The heritability estimate for overall infection in the
combined sample was lower and more significant than in
the two separate groups of psychiatric cases and controls.
Thus, adding psychiatric cases to the analysis (while
introducing a covariate for having a psychiatric diagnosis)
increased the sample size but reduced the heritability
estimate. In the individual groups, the heritability was
higher among psychiatric controls than among psychiatric
cases. This could suggest that, in individuals with a psy-
chiatric diagnosis, the environment may play a bigger role
in susceptibility to infection and/or that there are G × E
interactions driving this difference. Similarly, there could
be a special burden of infection-psychiatric pleiotropic
variants in psychiatric cases. It should above all be
emphasized that the observed-scale heritability in the two
groups did not differ significantly in our study, and, while
the question of what is behind this difference is extremely
interesting, this study cannot make an authoritative
statement on the subject in its current design. It should
also be noted that, given the individuals may be diagnosed
with infections later on, the lifetime risk estimate k,
employed in the transformation to the liability scale
(calculated from the random population sample), may
change, and, as our phenotype encompasses many ICD-10
codes, there are no past epidemiological studies providing
an estimate of lifetime risk. As we have examined the
heritability for several values of k, we believe our results
provide a sensible range for the heritability to suscept-
ibility to infection. However, as the true proportion of
cases may also change, as the sample ages, these figures
could change as well. That said, the SNP heritability
estimates we found were comparable to those reported for
common infections and infection-associated procedures
in a recent study relying on self-reported data11.
We observed an increased prevalence of infections
among individuals with mental disorders in our random
population sample, as well as a high degree of genetic
correlation between the two phenotypes, suggesting that,
at least, to some degree, this epidemiological observation
could be explained by considering the contribution from
shared polygenic factors. However, we have shown in a
previous study that the robust PRS for schizophrenia does
not predict the risk of acquiring infections23. The
observed genetic correlation could indicate a causal
overlap and an etiological role for infections in subgroups
of mental disorders. It might also be the case that infec-
tions and immune responses could have a triggering role
in the development of some mental disorders, with long-
lasting subsequent immune alterations in individuals with
mental disorders, as is suspected in autoimmune diseases,
where infections and susceptibility genes are considered
the main risk factors41. Moreover, socioeconomic and
educational factors might prove important, together with
periods of psychological stress or altered behavior, in
making the individual more susceptible to acquiring
infections. The genetic correlation between overall
infection and mental illness, together with the difference
in the heritabilities of the two traits, may suggest that the
same risk-inducing variants may have a bigger effect on
mental illness than on susceptibility to infection.
The GWAS did not identify genome-wide significant
SNPs; however, there were 90 suggestive SNPs. The top
SNP was rs6447952, an intronic SNP within SLIT2. Inter-
estingly, this gene has been reported to be involved in
immune response, namely, the SLIT2 protein inhibited
leukocyte chemotaxis42. Furthermore, this gene is also
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involved in brain development through neuronal migra-
tion43. As our GWAS controlled for psychiatric diagnosis,
this could be an interesting illustration of a complex genetic
factor, perhaps exhibiting pleiotropic effects and/or inter-
actions with other factors. More recently, this gene has been
highlighted in studies of schizophrenia and specific infec-
tions: Cytomegalovirus and Toxoplasma gondii, although
the associations with SNPs in this gene were not genome-
wide significant14,44. Thus, while no single SNP reached
genome-wide significance in our study, possibly due to
small effect sizes and a not-large-enough sample size, our
results might still be informative regarding potential can-
didate genes for infection, and for studying the genetic
overlaps between infection and mental disorders. However,
further studies and functional work are required to support
SLIT2 as a candidate gene for infection, given its only-
suggestive association in this study.
The connection between the immune system and psy-
chiatric disorders has been described in many studies; in
the case of the iPSYCH sample, a recent study found links
between ASD and intellectual disability and some HLA
alleles, while also investigating associations with the main
disorders represented in the cohort45 (see this study for an
outline of previous studies investigating these links).
Recently, a study of genetic correlation between auto-
immune and infection-related phenotypes and psychiatric
disorders reported interesting findings; while only one
infection category (childhood ear infection) was included,
it was significantly positively correlated with ADHD and
neuroticism and showed nominal association with
depression and angry temperament46. Another recent
study suggested that risky sexual behavior and schizo-
phrenia risk might have overlapping genetic bases, thus
explaining some of the epidemiological correlation
between schizophrenia and HIV infection47. These results
together with our study suggest a complex genetic picture
in relation to the link between infection, immunity and
psychiatric/behavioral phenotypes.
Strengths and limitations
The strengths of this study include the prospective
design and the population-based nationwide registers in
Denmark, ensuring a large study population where all
exposures were recorded independently of the outcome
and therefore were not subject to selection or recall bias,
with the Danish government health-care system being
free of charge. Additionally, studies have shown high
validity of both diagnoses with infections and mental
disorders in the Danish Registers48,49. Our infection
phenotype may be considered heterogeneous, when each
infection category or even each ICD-10 code could be
studied individually. However, in this study we chose to
investigate the general genetic pathways for susceptibility
to any type of infection, and defining the phenotype as
such allowed us to do so while at the same time increasing
the power of our analyses, as most of the infection cate-
gories include a small number of cases.
One limitation of our study is that the age groups
represented in this study are relatively young, and,
therefore, the lifetime prevalence of acquiring an infection
could not be determined. In the same vein, it is also
possible that the genetic factors that manifest suscept-
ibility to infection in later stages of life were not captured
here. As our dataset included diagnoses of only psychia-
tric/neurological conditions, infections, and autoimmune
diseases (which are correlated with psychiatric condi-
tions)50, we did not have an appropriate third category of
diseases within which we could examine the incidence of
infections. Furthermore, we could include only individuals
with hospital contact for infection; hence, the less severe
cases of infections were not included. However, this could
also be advantageous, as the investigated phenotypes have
been so severe as to require a hospital contact, meaning
that they may represent a more defined group. None-
theless, the potential impact of misclassification in the
individuals not recorded with infections could result in
the genetic associations in our study representing the
severity of infection rather than susceptibility to infection.
It should also be noted that our models do not incorpo-
rate the temporal component of the association between
infections and psychiatric disorders; as our phenotypes
were complex, and as they may represent more than one
infection and/or psychiatric disorder diagnosed in a given
individual, our study does not answer questions pertain-
ing to the directionality of this association. Moreover, the
genetic contribution might have been greater if studying
individuals with severe infections, where genetic sus-
ceptibility to infection might play a larger role. Even
though this is the largest GWAS to date on infections
requiring hospital contact, the included heterogeneous
groups of infections might warrant an even larger sample
to display the underlying genetic architecture of the sus-
ceptibility to infection using GWAS. Lastly, while using a
large sample from a homogenous population is advanta-
geous in that it eliminates certain confounders, especially
in terms of genetic variation, the results could prove to be
specific to the Danish population, as genetic associations
across populations can differ based on the presence of the
variant in one population but not others, difference in
allele frequencies when it is present in more than one
population, as well as differences in disease prevalence
and variant effect sizes across populations51.
In conclusion, we identified a polygenic architecture for
susceptibility to infection, with the PRS significantly
explaining some of the risk in an independent sample, and
found a modest heritability for susceptibility to infection
across independent samples. This study confirms the
presence of a genetic risk for acquiring infections and a
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genetic correlation with mental disorders, as well as the
high degree of comorbidity between the two. To this
effect, we propose that individuals presenting with psy-
chiatric pathology should also be screened for possible
infections. Larger-scale studies are warranted both in
relation to more precise infection phenotypes and sample
size, which could help elucidate the genetic architecture
of infectious diseases further.
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